Bufotenine

CAS No. 487-93-4

Bufotenine ( )

Catalog No. M31983 CAS No. 487-93-4

Bufotenine may have hallucinogenic potential, the presence and levels of bufotenine might be useful and important markers of some psychiatric disorders. Bufotenine is able to block rabies virus infection in BHK-21 cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Bufotenine
  • Note
    Research use only, not for human use.
  • Brief Description
    Bufotenine may have hallucinogenic potential, the presence and levels of bufotenine might be useful and important markers of some psychiatric disorders. Bufotenine is able to block rabies virus infection in BHK-21 cells.
  • Description
    Bufotenine may have hallucinogenic potential, the presence and levels of bufotenine might be useful and important markers of some psychiatric disorders. Bufotenine is able to block rabies virus infection in BHK-21 cells.
  • Synonyms
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    487-93-4
  • Formula Weight
    204.3
  • Molecular Formula
    C12H16N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.J Psychoactive Drugs. 2000 Jul-Sep;32(3):321-31.
molnova catalog
related products
  • Eptifibatide

    Eptifibatide an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue.

  • ISOTHIAZOLINE 1,1-DI...

    ISOTHIAZOLINE 1,1-DIOXIDE is a reactant used in the synthesis of orally bioavailable hebatits B caspid inhibitors, and in the preparation of cryptochrome imhibitors as antidiabetic agents.

  • DL-Pyroglutamic acid

    DL-Pyroglutamic acid exhibited a strong inactivating effect on hepatitis B surface antigen.?